
Mitochondrial ATP Preparation
Our ATP preparation is an innovative, laboratory-produced equivalent of adenosine triphosphate (ATP) – the basic energy molecule present in all living cells. Unlike naturally produced ATP, which degrades rapidly and is used inefficiently by the body (especially in conditions of aging or disease), this formulation is characterized by increased stability and durability. This allows the body to fully utilize ATP's potential as an energy carrier, neurotransmitter, and key regulator of repair and regeneration processes at the cellular level, thanks to its function in stimulating and protecting mitochondria.
Laboratory of the Highest Standards Collaborating with Foreign Research Laboratories
Toxicological Safety Accreditation
Years of Research Proving the Effectiveness of the Preparation
IMD Berlin Laboratory Report
The intracellular ATP level at the beginning of the study was 2.79 µM (lower reference range).
After approximately 6 weeks of using the preparation, a significant increase in intercellular ATP was observed, reaching 7.59 µM (upper reference range; additionally, no mitochondrial dysfunction was observed). This increase in ATP confirms mitochondrial stimulation and provides evidence of the effectiveness of oral administration of the preparation. On the day of the study, a daily dose of the preparation (50 ml) was also administered.
The ATP level after discontinuing the preparation for the next 6 weeks was 3.67 µM (the preparation was not taken from July 22, 2022, to October 14, 2022).
The measurement demonstrated that the effects achieved during treatment with the preparation are sustained mitochondrial stimulation, which, in the case of pathological conditions, indicates the effectiveness of limiting and eliminating changes.
ATP w Granulocytach
Granulocytes play a crucial role in the immune response, particularly in the fight against pathogens. ATP is essential for processes such as migration, phagocytosis, and degranulation, thereby enabling granulocytes to effectively protect the body. Granulocytes utilize ATP for migration and chemotaxis—facilitating rapid movement to sites of infection, where they carry out phagocytosis and degranulation, both of which are dependent on an adequate energy supply. By increasing ATP levels within granulocytes through the natural stimulation of mitochondria, the preparation strengthens the immune response; it also supports proper wound healing, which is another defensive function of granulocytes. While an excess of exogenous ATP—for instance, in the form of disodium adenosine—can potentially have negative effects if administered in excessive amounts, the key difference lies in the method of absorption, the formulation process, and the fact that this preparation, by stimulating mitochondrial ATP production, operates in a manner that preserves homeostasis.
In a male subject, an assessment conducted on April 22, 2024, showed an ATP level of 0.254 nmol in granulocytes; after two months of therapy with the preparation, this level rose to 0.522 nmol—an increase of 105.5%.
Meanwhile, in a female subject, a 121.3% increase in granulocyte ATP levels was observed, also following two months of using the preparation.











